Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Respir Med. 2013 Jan;107(1):139-46. doi: 10.1016/j.rmed.2012.10.019. Epub 2012 Nov 28.
The term "obesity paradox", refers to lower mortality rates in obese patients, and is evident in various chronic cardiovascular disorders. There is however, only scarce data regarding the clinical implication of obesity and pulmonary hypertension (PH). Therefore, in the current study, we evaluated the possible prognostic implications of obesity in PH patients.
We assessed 105 consecutive PH patients for clinical and hemodynamic parameters, focusing on the possible association between Body Mass Index (BMI) and mortality. Follow-up period was 19 ± 13 months.
Sixty-one patients (58%) had pre-capillary PH and 39 patients (37%) out-of-proportion post-capillary PH. During follow-up period, 30 patients (29%) died. Death was associated with reduced functional-class, inverse-relation with BMI, higher pulmonary artery and right atrial pressures, pulmonary vascular resistance and signs of right ventricular failure. In multivariate analysis, obesity (BMI ≥ 30 kg/m²), was the variable most significantly correlated with improved survival [H.R 0.2, 95% C.I 0.1-0.6; p = 0.004], even after adjustment for baseline characteristics. Obese and very-obese (BMI ≥ 35 kg/m²) patients had significantly less mortality rates during follow-up (12% and 8%, respectively) than non-obese patients (41%), p = 0.01. The tendency of survival benefit for the obese vs. non-obese patients was maintained both in the pre-capillary (10% vs. 46% mortality, p = 0.008) and disproportional post-capillary PH patients (11% vs. 40% mortality, p = 0.04).
Obesity was significantly associated with lower mortality in both pre-capillary and disproportional post-capillary PH patients. It seems that in PH, similarly to other chronic clinical cardiovascular disease states, there may be a protective effect of obesity, compatible with the "obesity paradox".
“肥胖悖论”是指肥胖患者死亡率较低的现象,在各种慢性心血管疾病中都有体现。然而,关于肥胖和肺动脉高压(PH)的临床意义的数据却很少。因此,在本研究中,我们评估了肥胖在 PH 患者中的可能预后意义。
我们评估了 105 例连续的 PH 患者的临床和血流动力学参数,重点关注体重指数(BMI)与死亡率之间的可能关联。随访时间为 19±13 个月。
61 例患者(58%)患有毛细血管前 PH,39 例患者(37%)患有不成比例的毛细血管后 PH。在随访期间,30 例患者(29%)死亡。死亡与功能分级降低、BMI 呈反比、肺动脉和右心房压力、肺血管阻力和右心衰竭迹象有关。多变量分析表明,肥胖(BMI≥30kg/m²)是与生存率改善最显著相关的变量[风险比 0.2,95%置信区间 0.1-0.6;p=0.004],即使在调整基线特征后也是如此。肥胖和非常肥胖(BMI≥35kg/m²)患者在随访期间的死亡率明显低于非肥胖患者(分别为 12%和 8%,而非肥胖患者为 41%,p=0.01)。在毛细血管前(死亡率分别为 10%和 46%,p=0.008)和不成比例的毛细血管后 PH 患者(死亡率分别为 11%和 40%,p=0.04)中,肥胖患者与非肥胖患者的生存获益趋势均保持一致。
肥胖与毛细血管前和不成比例的毛细血管后 PH 患者的死亡率显著降低相关。在 PH 中,与其他慢性临床心血管疾病状态一样,肥胖可能具有保护作用,与“肥胖悖论”相符。